Texolite Dry Fill
Product Description
Texolite Dry Fill was a construction and industrial product manufactured by United States Gypsum Company (USG), one of the dominant suppliers of building materials throughout the twentieth century. USG produced an extensive product line under various trade names, and Texolite Dry Fill was among those products formulated for use in commercial and industrial construction settings. Based on its name and product classification, Texolite Dry Fill was likely employed as a fill, leveling, or finishing compound used in conjunction with ceiling systems, wall assemblies, and related building components.
United States Gypsum held a commanding position in the American building materials market for decades, supplying products to commercial construction sites, industrial facilities, shipyards, power plants, and institutional buildings such as schools and hospitals. Like many manufacturers operating during the mid-twentieth century, USG incorporated asbestos fibers into a range of its product formulations during periods when asbestos was widely regarded as a cost-effective and technically advantageous additive for fireproofing, insulation, and durability.
Texolite Dry Fill falls within product categories that include ceiling tile, joint compound, and pipe insulation applications — categories historically associated with asbestos-containing materials during the peak decades of asbestos use in American industry, roughly spanning the 1940s through the late 1970s.
Asbestos Content
Litigation records document that Texolite Dry Fill was alleged to have contained asbestos as a component of its formulation. Plaintiffs alleged that the product, consistent with USG’s broader manufacturing practices during the relevant period, incorporated asbestos fibers — most commonly chrysotile, though amphibole varieties were also used in some building product lines — to achieve desired material properties such as fire resistance, binding strength, and dimensional stability.
The specific fiber type, concentration, and formulation details for Texolite Dry Fill as used across different production runs are not fully established in publicly available documentation. However, litigation records document that products in the joint compound, ceiling tile, and fill material categories manufactured by USG during the mid-twentieth century were alleged to have contained measurable percentages of asbestos by weight.
Under standards later established by the Asbestos Hazard Emergency Response Act (AHERA) and enforced by the Environmental Protection Agency, materials containing more than one percent asbestos by weight are classified as asbestos-containing materials (ACMs) subject to regulated abatement procedures. Plaintiffs alleged that Texolite Dry Fill met or exceeded this threshold during its production years.
How Workers Were Exposed
Industrial workers represent the primary occupational group documented in connection with Texolite Dry Fill exposure. The product’s classification across ceiling tile, joint compound, and pipe insulation categories suggests it was handled in a variety of trade settings where dry mixing, application, cutting, sanding, and finishing operations were routine.
Mixing and Application: Workers who mixed dry fill compounds in preparation for application were potentially exposed to airborne asbestos fibers released during the agitation of powdered or granular material. Dry mixing is consistently identified in occupational health literature as a high-exposure task because it generates significant airborne dust concentrations before any liquid is incorporated.
Sanding and Finishing: Joint compound and fill material products typically required sanding after application and drying. Sanding asbestos-containing compounds generates fine respirable dust. OSHA and regulatory records have consistently identified dry sanding of asbestos-containing joint compounds as a task capable of producing airborne fiber concentrations well above permissible exposure limits established under modern standards.
Ceiling and Wall Assembly Work: Workers involved in the installation and finishing of ceiling tile systems and wall assemblies, including those cutting tile to fit irregular spaces, would have released asbestos fibers through mechanical disruption of the material. Industrial workers in facilities where such assemblies were constructed, maintained, or demolished faced both primary and secondary exposure risks.
Pipe Insulation Context: To the extent Texolite Dry Fill was used in pipe insulation applications, workers applying fill material around pipe systems in industrial facilities — including power plants, refineries, and manufacturing plants — faced repeated close-contact exposure. Pipefitters, insulators, and general laborers working in proximity to pipe insulation application were among those potentially affected.
Bystander and Secondary Exposure: Litigation records document that plaintiffs alleged exposure not only through direct product handling but also through proximity to other workers using Texolite Dry Fill in shared workspaces. In industrial environments with limited ventilation, airborne fibers generated by one trade group could settle on surfaces and be re-entrained by subsequent workers, extending exposure beyond the immediate application task.
The latency period for asbestos-related diseases — including mesothelioma, asbestosis, and asbestos-related lung cancer — typically ranges from 10 to 50 years following initial exposure. This means workers exposed to Texolite Dry Fill during its peak production and installation years may only now be receiving diagnoses of asbestos-related illness.
Documented Trust Fund / Legal Options
Texolite Dry Fill is classified as a Tier 2 — Litigated product. There is no dedicated asbestos bankruptcy trust fund established specifically for United States Gypsum claims of this nature, as USG did not undergo the Chapter 11 asbestos bankruptcy reorganization process that resulted in the creation of a 524(g) trust fund. Accordingly, legal remedies for individuals alleging injury from Texolite Dry Fill exposure are pursued through the civil tort litigation system rather than through an administrative trust fund claims process.
Civil Litigation: Litigation records document that plaintiffs alleging injury from exposure to USG products, including those in the Texolite product line, have filed personal injury and wrongful death claims in state and federal courts. Plaintiffs alleged that United States Gypsum knew or should have known of the hazards associated with asbestos in its products and failed to adequately warn workers of those risks.
Available Claims: Individuals diagnosed with mesothelioma, asbestosis, asbestos-related lung cancer, or other asbestos-related conditions following documented or alleged exposure to Texolite Dry Fill may have grounds to pursue:
- Personal injury claims alleging negligence, failure to warn, and products liability
- Wrongful death claims filed by surviving family members on behalf of deceased workers
- Loss of consortium claims in applicable jurisdictions
Documentation Relevant to Claims: Persons pursuing litigation related to Texolite Dry Fill exposure should work with legal counsel to document employment history at worksites where the product was used, co-worker testimony identifying the specific product, medical records confirming an asbestos-related diagnosis, and any product identification records such as invoices, material safety data sheets, or construction specifications referencing Texolite Dry Fill.
Statute of Limitations: Deadlines for filing asbestos-related claims vary by state and are typically measured from the date of diagnosis rather than the date of exposure, given the recognized latency period of asbestos disease. Consulting a qualified asbestos litigation attorney promptly following diagnosis is strongly advised to preserve legal rights.
Individuals who believe they were exposed to Texolite Dry Fill in the course of industrial work should seek evaluation by a physician experienced in occupational lung disease and consult with an attorney who specializes in asbestos litigation to assess available legal options.